114 related articles for article (PubMed ID: 37837384)
21. Upregulated TRIM29 promotes proliferation and metastasis of nasopharyngeal carcinoma via PTEN/AKT/mTOR signal pathway.
Zhou XM; Sun R; Luo DH; Sun J; Zhang MY; Wang MH; Yang Y; Wang HY; Mai SJ
Oncotarget; 2016 Mar; 7(12):13634-50. PubMed ID: 26872369
[TBL] [Abstract][Full Text] [Related]
22. LncRNA BDNF-AS suppresses colorectal cancer cell proliferation and migration by epigenetically repressing GSK-3β expression.
Zhi H; Lian J
Cell Biochem Funct; 2019 Jul; 37(5):340-347. PubMed ID: 31062382
[TBL] [Abstract][Full Text] [Related]
23. LINC01116 promotes proliferation, invasion and migration of osteosarcoma cells by silencing p53 and EZH2.
Zhang ZF; Xu HH; Hu WH; Hu TY; Wang XB
Eur Rev Med Pharmacol Sci; 2019 Aug; 23(16):6813-6823. PubMed ID: 31486480
[TBL] [Abstract][Full Text] [Related]
24. CircIL4R activates the PI3K/AKT signaling pathway via the miR-761/TRIM29/PHLPP1 axis and promotes proliferation and metastasis in colorectal cancer.
Jiang T; Wang H; Liu L; Song H; Zhang Y; Wang J; Liu L; Xu T; Fan R; Xu Y; Wang S; Shi L; Zheng L; Wang R; Song J
Mol Cancer; 2021 Dec; 20(1):167. PubMed ID: 34922544
[TBL] [Abstract][Full Text] [Related]
25. TRIM29 promotes progression of thyroid carcinoma via activating P13K/AKT signaling pathway.
Xu J; Li Z; Su Q; Zhao J; Ma J
Oncol Rep; 2017 Mar; 37(3):1555-1564. PubMed ID: 28098872
[TBL] [Abstract][Full Text] [Related]
26. Long non‑coding RNA TP73‑AS1 accelerates the progression and cisplatin resistance of non‑small cell lung cancer by upregulating the expression of TRIM29 via competitively targeting microRNA‑34a‑5p.
Luo S; Shen M; Chen H; Li W; Chen C
Mol Med Rep; 2020 Nov; 22(5):3822-3832. PubMed ID: 32901838
[TBL] [Abstract][Full Text] [Related]
27. microRNA-761 induces aggressive phenotypes in triple-negative breast cancer cells by repressing TRIM29 expression.
Guo GC; Wang JX; Han ML; Zhang LP; Li L
Cell Oncol (Dordr); 2017 Apr; 40(2):157-166. PubMed ID: 28054302
[TBL] [Abstract][Full Text] [Related]
28. The SLC34A2-ROS-HIF-1-induced up-regulation of EZH2 expression promotes proliferation and chemo-resistance to apoptosis in colorectal cancer.
Li X; Xing J; Wang H; Yu E
Biosci Rep; 2019 May; 39(5):. PubMed ID: 30038060
[TBL] [Abstract][Full Text] [Related]
29. lncRNA ELFN1-AS1 upregulates TRIM29 by suppressing miR-211-3p to promote gastric cancer progression.
Huang J; Yuan W; Chen B; Li G; Chen X
Acta Biochim Biophys Sin (Shanghai); 2023 Mar; 55(3):484-497. PubMed ID: 36876422
[TBL] [Abstract][Full Text] [Related]
30. Long Non-Coding RNA SH3PXD2A-AS1 Promotes Cell Progression Partly Through Epigenetic Silencing P57 and KLF2 in Colorectal Cancer.
Ma Z; Peng P; Zhou J; Hui B; Ji H; Wang J; Wang K
Cell Physiol Biochem; 2018; 46(6):2197-2214. PubMed ID: 29734178
[TBL] [Abstract][Full Text] [Related]
31. MicroRNA-424-5p acts as a potential biomarker and inhibits proliferation and invasion in hepatocellular carcinoma by targeting TRIM29.
Du H; Xu Q; Xiao S; Wu Z; Gong J; Liu C; Ren G; Wu H
Life Sci; 2019 May; 224():1-11. PubMed ID: 30876939
[TBL] [Abstract][Full Text] [Related]
32. Downregulated LINC00628 aggravates the progression of colorectal cancer via inhibiting p57 level.
Zhang MC; Zhang L; Zhang MQ; Yang GX; Wang FZ; Ding P
Eur Rev Med Pharmacol Sci; 2020 Feb; 24(4):1763-1770. PubMed ID: 32141544
[TBL] [Abstract][Full Text] [Related]
33. EZH2 promotes colorectal cancer stem-like cell expansion by activating p21cip1-Wnt/β-catenin signaling.
Chen JF; Luo X; Xiang LS; Li HT; Zha L; Li N; He JM; Xie GF; Xie X; Liang HJ
Oncotarget; 2016 Jul; 7(27):41540-41558. PubMed ID: 27172794
[TBL] [Abstract][Full Text] [Related]
34. TRIM29 prevents hepatocellular carcinoma progression by inhibiting Wnt/β-catenin signaling pathway.
Xu M; Hu J; Zhou B; Zhong Y; Lin N; Xu R
Acta Biochim Biophys Sin (Shanghai); 2019 Jan; 51(1):68-77. PubMed ID: 30566565
[TBL] [Abstract][Full Text] [Related]
35. Down-regulation of EZH2 genes targeting RUNX3 affects proliferation, invasion, and metastasis of human colon cancer cells by Wnt/β-catenin signaling pathway.
Liang G; Han L; Qu M; Xue J; Xu D; Wu X; Lu Y
Aging (Albany NY); 2023 Dec; 15(23):13655-13668. PubMed ID: 38048186
[TBL] [Abstract][Full Text] [Related]
36. E3 ubiquitin ligase TRIM29 promotes pancreatic cancer growth and progression via stabilizing Yes-associated protein 1.
Deng X; Fu X; Teng H; Fang L; Liang B; Zeng R; Chen L; Zou Y
J Transl Med; 2021 Aug; 19(1):332. PubMed ID: 34353343
[TBL] [Abstract][Full Text] [Related]
37. Involvement of aberrantly activated HOTAIR/EZH2/miR-193a feedback loop in progression of prostate cancer.
Ling Z; Wang X; Tao T; Zhang L; Guan H; You Z; Lu K; Zhang G; Chen S; Wu J; Qian J; Liu H; Xu B; Chen M
J Exp Clin Cancer Res; 2017 Nov; 36(1):159. PubMed ID: 29141691
[TBL] [Abstract][Full Text] [Related]
38. EZH2 Promotes Multiple Myeloma Progression via STAT3 Pathway Activation.
Wang Y; Tian J; Huang D; Gao Y; Lin H; Liu L; Wang A
Discov Med; 2024 Apr; 36(183):721-729. PubMed ID: 38665021
[TBL] [Abstract][Full Text] [Related]
39. lncRNA TUG1 inhibits the cancer stem cell‑like properties of temozolomide‑resistant glioma cells by interacting with EZH2.
Cao Y; Chai W; Wang Y; Tang D; Shao D; Song H; Long J
Mol Med Rep; 2021 Jul; 24(1):. PubMed ID: 34036375
[TBL] [Abstract][Full Text] [Related]
40. miR-34c-5p mediates the cellular malignant behaviors of oral squamous cell carcinoma through targeted binding of TRIM29.
Shen Y; Sun C; Zhao B; Guo H; Li J; Xia Y; Liu M; Piao S; Saiyin W
Ann Transl Med; 2021 Oct; 9(20):1537. PubMed ID: 34790743
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]